@davenjoe76 Yes. I believe so. Humans were immunized with 100 μg mRNA-1273 on a prime-boost schedule and sera was collected 1 week post the boost (day 36). From this study. https://t.co/ewATnCOBHq
mRNA😱😖🤐😇は去年11月の速報でこんなこといってますんでね
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
@GovSisolak Mr. Aaron got the Moderna.... https://t.co/qMnIfOwu19
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
RT @LynnFynn3: Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you…
Remember, for a reported novel "virus" that fails to cause symptoms in the majority of people, #Moderna can insure that you get sick (even more so after the second jab) ... to maybe diminish the symptoms of the thing that mostly doesn't make you sick. http
RT @MonicaGandhi9: Here is Moderna neutralizing antibody titers generated after doses (100 micrograms was chosen as dose going forward) htt…
Here is Moderna neutralizing antibody titers generated after doses (100 micrograms was chosen as dose going forward) https://t.co/y9IWz5GP4r https://t.co/vw15iWIoGH
@kimrase An mRNA Vaccine against SARS-CoV-2 — Preliminary Report https://t.co/BTKcZZlie3
@sweis @octal The Moderna phase 1 trial looked at immune response. https://t.co/kGO3o2X72M But anyway my meaning is that some people, maybe including @octal, are ok with getting vaccine without a ton of safety and efficacy data but no way can you do a gen
RT @MonicaGandhi9: A few things about the vaccines. The preliminary report about the Moderna mRNA vaccine from NEJM Nov 12 (100 microgram…
A few things about the vaccines. The preliminary report about the Moderna mRNA vaccine from NEJM Nov 12 (100 microgram dose chosen) reminds us the mRNA codes for the SARS-CoV-2 spike protein with a transmembrane anchor. Table 2 shows us antibodies https
@bornwithnolegs @ScottyWitte @deeptabhattacha @florian_krammer MRNA: see fig S9-11: https://t.co/ojKcuvGksq
@DrEricDing @nicd_sa Pfizer’s data seems to be ok on CD4 and CD8 T cells but Moderna’s abstract said little to no CD8 T cell response. https://t.co/GVVNKAb5Qt https://t.co/oeKnvtQdou
RT @BartholemewKum1: @GuthmillerJenna I’m glad you got the Pfizer shot but are you concerned that the Moderna vaccine data stated little to…
@GuthmillerJenna I’m glad you got the Pfizer shot but are you concerned that the Moderna vaccine data stated little to no CD8 T cell response? I don’t see enough coverage about this. https://t.co/g8hHT1B7e5 https://t.co/LOJZWD5BCh
@Vanderstichel19 @YvesCoppieters Les premiers à avoir publié la phase 1 était Moderna le 14/7/20..... et c’était déjà prometteur. Petite firme donc Pfizer a pris la tête logiquement et midecembre plusieurs études phases 2/3 Astra ... on savait que ces vacc
RT @DocEvenhouse: These are small trials. No long term assessments done. Sure, let's roll it out worldwide cuz COVID. https://t.co/SkXvZ6…
@RobinHoorelbeke @Ruben_DeHerdt @destandaard https://t.co/4p1pYJtTiO en https://t.co/Fgqu4dj8nG en zo zijn er véél studies gebeurd hoor ... https://t.co/6E14pySDTb
An mRNA mRNA-1273 (Moderna) vaccine against SARS-CoV-2: Preliminary (phase 1) Report, : https://t.co/NNpzspi3Fh, phase 3 report: https://t.co/7r50qrWeui
RT @drhalat: An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM https://t.co/mOzJIcdgjb
RT @NIACINcuresCOV: ... all for a measly <1% increased gain (vs. placebo) in protection against developing #COVID19, which you have a <1% l…
RT @NIACINcuresCOV: ... all for a measly <1% increased gain (vs. placebo) in protection against developing #COVID19, which you have a <1% l…
RT @DrDark_Angel: No olvidemos por favor que las vacunas HASTA EL 11 DE ENERO DEL 2021, solo han demostrado dar inmunidad POR 4 MESES NADA…
RT @NIACINcuresCOV: ... all for a measly <1% increased gain (vs. placebo) in protection against developing #COVID19, which you have a <1% l…
RT @DrDark_Angel: No olvidemos por favor que las vacunas HASTA EL 11 DE ENERO DEL 2021, solo han demostrado dar inmunidad POR 4 MESES NADA…
RT @DrDark_Angel: No olvidemos por favor que las vacunas HASTA EL 11 DE ENERO DEL 2021, solo han demostrado dar inmunidad POR 4 MESES NADA…
RT @DrDark_Angel: No olvidemos por favor que las vacunas HASTA EL 11 DE ENERO DEL 2021, solo han demostrado dar inmunidad POR 4 MESES NADA…
RT @DrDark_Angel: No olvidemos por favor que las vacunas HASTA EL 11 DE ENERO DEL 2021, solo han demostrado dar inmunidad POR 4 MESES NADA…
RT @DrDark_Angel: No olvidemos por favor que las vacunas HASTA EL 11 DE ENERO DEL 2021, solo han demostrado dar inmunidad POR 4 MESES NADA…
RT @DrDark_Angel: No olvidemos por favor que las vacunas HASTA EL 11 DE ENERO DEL 2021, solo han demostrado dar inmunidad POR 4 MESES NADA…
RT @DrDark_Angel: No olvidemos por favor que las vacunas HASTA EL 11 DE ENERO DEL 2021, solo han demostrado dar inmunidad POR 4 MESES NADA…
No olvidemos por favor que las vacunas HASTA EL 11 DE ENERO DEL 2021, solo han demostrado dar inmunidad POR 4 MESES NADA MÁS. Asi que muy curativas no son, tampoco se emocionen mucho. fuente: https://t.co/XX6PatOoEt
RT @NIACINcuresCOV: ... all for a measly <1% increased gain (vs. placebo) in protection against developing #COVID19, which you have a <1% l…
RT @InsaneinyerBane: @cresshead3d @MRSS11224611 There are far more grounds to be skeptical over this radically experimental new form of vax…
RT @EMPoisonPharmD: The SARS-COV-2 Spike protein is 1273 AA long. https://t.co/iGAIdK41CJ This means it takes roughly 5728 ATP (4.5 ATP x…
The SARS-COV-2 Spike protein is 1273 AA long. https://t.co/iGAIdK41CJ This means it takes roughly 5728 ATP (4.5 ATP x 1273 AA) per spike protein you produce. This doesn't include energy for starting translation or packaging into a vesicle etc...purely
@bigmike_ak @annezinkmd FYI and for reference https://t.co/47aC6svH42
@Havanaclublover @sputnikvaccine @mfa_russia Who said completed? Just preliminary results (as Pfizer, Astra-Zeneca, and Moderna all have) would be great. Eg https://t.co/g3DUlmvhev.
RT @fredlapo93: Et bien ci ! Les premiers patients sont été inclus dans les études en Mars... https://t.co/KNs3gxFEHd https://t.co/zwhOaGvM…
Et bien ci ! Les premiers patients sont été inclus dans les études en Mars... https://t.co/KNs3gxFEHd
RT @PatRadix: Václav Klaus dnes na demonstraci prohlásil, že "žádná efektivní vakcína neexistuje!" Předpokládám, že tedy také četl, ale nes…
RT @PatRadix: Václav Klaus dnes na demonstraci prohlásil, že "žádná efektivní vakcína neexistuje!" Předpokládám, že tedy také četl, ale nes…
@maniletchumanan I saw your tweet about ingredients and I am not letting you go off the hook on that. In case you missed the train https://t.co/00SDjG24ta (Moderna) Here's the sequence: https://t.co/fiq2OFBVQH https://t.co/OBAQEzYJVI
RT @PatRadix: Václav Klaus dnes na demonstraci prohlásil, že "žádná efektivní vakcína neexistuje!" Předpokládám, že tedy také četl, ale nes…
Václav Klaus dnes na demonstraci prohlásil, že "žádná efektivní vakcína neexistuje!" Předpokládám, že tedy také četl, ale nesouhlasí se závěry https://t.co/wPPWaMr9Wj ani https://t.co/IvKMmFUuDz . Dal někam seznam konkrétních bodů, které jsou podle něj špa
@abbynac For mRNA vaxes, titers 7 days post-dose-2 were measured and comparable to Covid patients PFE/BNT: https://t.co/V4lgQgfArQ MRNA: https://t.co/j1gaWq5esM For NVAX, 14 days post-dose 2 titers were very high, but even 3 weeks post-dose-1 not bad: ht
@arianchazarreta Las vacunas de Moderna y Pfizer han completado con éxito la fase 1 y 2, en las que se estudia la seguridad del tratamiento: https://t.co/BdT11jO7Ei https://t.co/gVhtPVdHI1
RT @HironoriFunabi1: 最近、Moderna社がmRNAワクチン臨床試験で期待させる報告を出しているし、Oxfordのチームや、阪大関連のアンジェスなど、世界各国で超速で開発が進んでいる。ただ、ワクチンの効用、副作用については、まだまだ未知であり、慎重さも要求…
@DanaHolmes911 @i_yakoub_agha @BldCancerDoc @drjgauthier @GruppSteve @charliecraddock @AnnalisaRugger1 @RDuarte_EBMT @TheEBMT_Nurses @StevenPavletic @SanchezGuijoF @OnidaFrancesco @pebarba Not here: Jackson et al. An mRNA Vaccine against SARS-CoV-2 — Preli
(6/8) Las vacunas se han ensayado en personas SANAS‼️ https://t.co/nNl6Yk7A1y
@maelstrom0011 Да. Данные в свободном доступе: https://t.co/uKcyTwoHqA https://t.co/buwapYeUna Плюс обширная информация например от EMA. https://t.co/l1wynrY4kH
@obsesiones21 @snefru23 LOs de la de Moderna https://t.co/exYRSJFf8p
התוצאות הראשוניות של ניסויי החיסון של מודרנה https://t.co/xtixa3XfLI
@jairjaera Uma coisa tipo isso https://t.co/hO9DSY0Kak
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM https://t.co/wzEw7dAfKa
Another discussion: give 1/2 dose of the moderna vaccine. based on early clinical trials (Phase 1/2) suggesting smaller doses had similar Ab response in adults aged 18-55 yrs. But does this translate to efficacy and what is the durability of immunity? htt
@BanzirouGuava @doburoku009 RNAとしての安定化のため,S2サブユニットの中央らせんにあるアミノ酸位置986と987に連続してプロリン置換を入れている らしい。 https://t.co/vjJ5NfHltI
@pippanie @GregorianHumor @halvorz Snippets: The lipid nanoparticle capsule composed of four lipids was formulated in a fixed ratio of mRNA and lipid. The vaccine was administered as a 0.5-ml injection in the deltoid muscle https://t.co/f7QGa6AHNf
@Dereklowe /9 Here is the phase-I, n=45 dosing study. No one tried 50-μg. No interval other than 28 was tested. No single-dose regimen was tested (it was rather explicitly rejected). Min time to complete 50-μg study for interim results is suggested at t
RT @KizzyPhD: @Boughthemallout This is an explainer using our own phase 1 trial data... https://t.co/ZuETLEFi3Z
RT @wgibson: Note in panel d) that the 25 x2 dose was better than convalescent plasma for viral neutralization. Above data available at: ht…
@PowerDNS_Bert I’ve been able to find these articles that might be of interest: https://t.co/EdpTr9MiEm https://t.co/TxuRjQWEdA https://t.co/267BRBiCWH
Note in panel d) that the 25 x2 dose was better than convalescent plasma for viral neutralization. Above data available at: https://t.co/GWqe3UVNf2 So far we've seen 1/10th the dose x2 is qualitatively as good as 100 ug in primates and 1/4th the dose (25
@GaitGerritje @RTLnieuws Je hebt helemaal gelijk “gait” en hier is het hele medische onderzoek...als je het tenminste kunt lezen en begrijpen 😂https://t.co/Wstgy55bE9
RT @CaribeWellness: Me 'graphsplaining' 😅 Adapted from NEJM article (their full original publication accessible at https://t.co/mr1F1RtupO…
@Boughthemallout This is an explainer using our own phase 1 trial data...
ผลตัวเต็มของ phase 1/2 trial Pfizer มาตอน สค https://t.co/rLj0RumtTn ของ Moderna มาตอนพย. https://t.co/56peFuLzTK ส่วน phase 3 ก็ธค.คู่
@geller_mic @AArgoetti @rutihersh @Nadav_Eyal מודרנא בדקו מינון של 25 מקג מול 100 מקג. 25 מקג היה בבירור פחות טוב משמעותית בכל מדדי הנוגדנים ותאי T. (פייזר נותנים מנה באותו סדר גודל, 30 מקג). 50 מקג סביר שיהיו יותר טובים, השאלה אם כבר יגיע לאותה רמה כמו 10
RT @NealBrowning: @sangxa Blood was drawn at 1 week intervals during the first 2 months to monitor. According to the data published in the…
@angie_rasmussen @apoorva_nyc Moderna’s vaccine has *some* B cells and *zero* T cells. A complete immune response including both neutralizing antibodies AND B and T cells is needed for long term immunity. https://t.co/pNVswg61xZ https://t.co/EsKKRDLpL5
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
RT @KludkowskaM: Jest już praca naukowa podsumowująca badania nad szczepionką 💉 Moderny! Opublikowana w @NEJM (‼️❤️😚)! Z pracy tej pochodzi…
@DirkNiemann3 @robinalexander_ @welt Ich wäre vorsichtig die Impfstoffe von moderna u. Astrazeneca hinsichtlich einer "schnellen" EMA Zulassung auf eine Stufe zu stellen. Moderna hat bereits eine fda Zulassung und Ergebnisse publiziert. AZ hat bisher nur s